Bellipharma SRL
2.3 FTEThe score of Bellipharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -18 % Total assets +44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Bellipharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −9,471 € | ||||
| Equity | 214,395 € | ||||
| Cash | 57,555 € | ||||
| EBITDA | 18,216 € | ||||
| Total assets | 718,811 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 17 Dec 2025
- Year ended 31 Dec 2023filed on 01 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 25 Aug 2022
Bellipharma's financial analysis
- Solvency29.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Bellipharma
Bellipharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0844.039.461
- VAT number
- BE0844039461
- Peppol
- Registered · 0208:0844039461 · as of 08 Nov 2026
- Legal form
- SRL
- Incorporated
- 29 Feb 2012
- Registered office
- 1030 Schaerbeek
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Bellipharma (SRL) has been based in Schaerbeek since 2012, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 9,471 € and equity of 214,395 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 29.8%, below the median of its sector (37.8%).
Companies similar to Bellipharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie D'Ottignies Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 718,979 €
- Apotheek Van den Broeck Bevel Retail sale of pharmaceutical products Nijlen · balance sheet 718,559 €
- Pharmagilly Retail sale of pharmaceutical products Charleroi · balance sheet 717,024 €
- Pharmatrust Retail sale of pharmaceutical products Anderlecht · balance sheet 716,875 €
- Het Apotheekhuis Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 720,768 €
- Recipe Retail sale of pharmaceutical products Anderlecht · balance sheet 720,928 €
- MRZK Pharma Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet 721,142 €
- VAN DEN Abeele - Waerniers Retail sale of pharmaceutical products Maldegem · balance sheet 721,160 €
Frequently asked questions about Bellipharma
What is the revenue of Bellipharma?
Bellipharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Bellipharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0844039461 for Bellipharma, if the company is VAT-registered. Its company number (CBE) is 0844.039.461.
Where is the registered office of Bellipharma?
According to the CBE register, the registered office of Bellipharma is in 1030 Schaerbeek.
What is the equity of Bellipharma?
At the close of the 2025 financial year, the equity of Bellipharma amounts to 214,395 €, a solvency of 29.8% of total assets.
How many people work at Bellipharma?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Bellipharma?
The register lists 3 active mandates at Bellipharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Bellipharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →